Seattle, Washington / ACCESSWIRE / July 23, 2024 / Anarti Therapeutics is proud to announce promising data from an in vitro study conducted at Dabur Research Foundation. The results of this study indicate a potential biological mechanism of action by which Anarti Therapeutics’ Ayurvedic CBD Relief Oil may help relieve chronic pain associated with fibromyalgia. The product is now available to purchase online at https://anarti.us/.
1.First of all
Known for its therapeutic properties, Anarti’s Ayurvedic CBD Relief Oil has been the subject of an in-vitro study at Davar Research Foundation. The study aimed to evaluate the oil’s anti-inflammatory properties, with significant findings supporting the oil’s potential as an effective anti-inflammatory agent.
2. Research Objective
The main aim of this study was to investigate the anti-inflammatory effects of Anarti Relief Oil at the cellular level. Researchers focused on how the oil affects inflammatory markers and cytokine production in vitro.
3. Methodology
In this in vitro study, we used human cell lines known to be involved in inflammatory responses. Key aspects of the methodology are as follows:
-
Cell culture: Human monocytes were cultured and treated with different concentrations of Anarti’s Relief Oil.
-
Inflammatory Stimuli: Cells were stimulated with lipopolysaccharide (LPS) to induce an inflammatory response.
-
process: Different concentrations of Anarti’s Relief Oil were administered to the cell cultures.
-
Measurement of inflammatory markers: The levels of proinflammatory cytokines (TNF-α, IL-6, and IL-8) were measured using ELISA assays.
4. Results
Key findings from this study:
-
Reduction of pro-inflammatory cytokines: Anarti’s Relief Oil significantly reduced the cytokine levels of TNF-α, IL-6, and IL-8 compared to the control group.
-
Cell viability: Treatment with Anarti Relief Oil did not adversely affect cell viability, indicating that the observed anti-inflammatory effects were not due to cytotoxicity.
5. Discussion
Results from in-vitro studies suggest that Anati Relief Oil has potent anti-inflammatory properties. Reductions in pro-inflammatory cytokines (IL-6, IL-8, TNF-α) highlight its potential mechanism of action. These results are consistent with the known benefits of the active ingredients in Anati Relief Oil, which include CBD and other natural plant-derived compounds that have been shown to have anti-inflammatory effects.
6. Conclusion
Compelling in vitro study results highlight the promise of Anarti’s Relief Oil as an effective anti-inflammatory agent. Anarti’s Relief Oil shows promise as a natural remedy for managing inflammation and related symptoms, providing a valuable addition to the arsenal of anti-inflammatory treatments.
The full survey results are available at here
Founder’s Story
Alka Badshah, founder of Anarti Therapeutics, has been battling chronic pain and fatigue caused by fibromyalgia for 25 years. Through extensive research and experimentation with plant-based solutions, she discovered a powerful blend of Ayurveda and CBD that provided pain relief without harmful chemicals. This breakthrough discovery has transformed her quality of life. After experiencing results for five years, she invites you to join the Anarti revolution and experience true pain relief and recovery.
Alka Badshah said, “This achievement has become my life’s purpose. The results found in the study scientifically prove what I have been experiencing for the past five years. There are millions of people who silently suffer from this condition. Every time I hear of someone who has benefited from these products – sleeping better, having days with less pain or regaining activities they had given up – it gives me immense joy and a sense of fulfillment towards my goal of helping people.”
Chronic Pain and Fibromyalgia: A Global Burden
In the United States, approximately 50 million adults suffer from chronic pain, of which approximately 4 million have fibromyalgia. Globally, approximately 1.5 billion people suffer from chronic pain. Fibromyalgia affects 2-4% of the world’s population, affecting approximately 150-300 million people worldwide. These statistics highlight the significant impact that chronic pain and fibromyalgia have on global health. Fibromyalgia is more prevalent in women, with women accounting for 75-90% of diagnosed cases.
Product Availability
Ayurvedic CBD Relief Oil, along with Anarti Therapeutics’ other plant-based therapeutic products, are now available for purchase through the company’s direct-to-consumer store, www.anarti.us .
About Davar Research Foundation
Dabur Research Foundation (DRF) is focused on studying and leveraging the biology of Ayurvedic plants and their active ingredients to develop high-quality, scientifically proven herbal products. With over 100 years of cumulative experience and over 10,000 preclinical studies, DRF has established itself as a key player in the field of research and development. Notable partners include prestigious institutions such as Harvard Medical School, Oxford University, and the Hebrew University of Jerusalem, known for their advancements in cannabis research and development.
About Founder Alka Badshah
Mr. Badshah holds an MS from Massachusetts Institute of Technology (MIT) and has over 20 years of experience in technology and currently lives in Seattle, Washington.
About Anarti Therapeutics
Anarti Therapeutics (Meher LLC dba Anarti Therapeutics, a Western Australian company) is committed to providing innovative plant-based solutions for chronic pain and inflammation. With a focus on scientific research and natural healing, Anarti Therapeutics aims to improve the quality of life for people suffering from chronic pain.
contact address:
Analty Therapeutics
Alka Badshah
Founder/CEO
(425) 442-5560
[email protected]
https://anarti.us
sauce: Analty Therapeutics
